Weibin Shi

1.4k total citations
30 papers, 756 citations indexed

About

Weibin Shi is a scholar working on Biomaterials, Molecular Biology and Cancer Research. According to data from OpenAlex, Weibin Shi has authored 30 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 9 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Weibin Shi's work include Nanoparticle-Based Drug Delivery (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). Weibin Shi is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). Weibin Shi collaborates with scholars based in China, Australia and Japan. Weibin Shi's co-authors include Jianwen Liu, Xin Liang, Meidong Lang, Jing Ding, Changchun Wang, Jia Guo, Peng Yang, Vanminh Le, Sha Jin and Yixin Wu and has published in prestigious journals such as Biomaterials, Chemistry of Materials and Langmuir.

In The Last Decade

Weibin Shi

29 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weibin Shi China 15 294 260 228 219 98 30 756
Seung Rim Hwang South Korea 16 569 1.9× 202 0.8× 185 0.8× 191 0.9× 98 1.0× 38 1.0k
Claudia Bellomo Sweden 11 324 1.1× 211 0.8× 212 0.9× 119 0.5× 234 2.4× 15 899
Ting Shan China 18 406 1.4× 190 0.7× 122 0.5× 257 1.2× 58 0.6× 36 888
Shuo Liu China 13 200 0.7× 284 1.1× 209 0.9× 72 0.3× 104 1.1× 41 770
Ali Fotouhi Iran 11 248 0.8× 206 0.8× 168 0.7× 99 0.5× 158 1.6× 15 719
Seung Woo Chung South Korea 20 493 1.7× 290 1.1× 270 1.2× 118 0.5× 257 2.6× 47 1.0k
Xiaoya Zhao China 15 350 1.2× 298 1.1× 111 0.5× 160 0.7× 101 1.0× 33 763
Qinglian Wen China 18 284 1.0× 195 0.8× 172 0.8× 161 0.7× 164 1.7× 48 756
Shaobo Xue China 12 289 1.0× 136 0.5× 109 0.5× 135 0.6× 100 1.0× 20 664
Yan Wei China 19 381 1.3× 296 1.1× 269 1.2× 110 0.5× 143 1.5× 28 866

Countries citing papers authored by Weibin Shi

Since Specialization
Citations

This map shows the geographic impact of Weibin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibin Shi more than expected).

Fields of papers citing papers by Weibin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibin Shi. The network helps show where Weibin Shi may publish in the future.

Co-authorship network of co-authors of Weibin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Weibin Shi. A scholar is included among the top collaborators of Weibin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibin Shi. Weibin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shouhua, et al.. (2024). ALKBH5-mediated m6A modification of circFOXP1 promotes gastric cancer progression by regulating SOX4 expression and sponging miR-338-3p. Communications Biology. 7(1). 565–565. 13 indexed citations
2.
Zhu, Xiang, et al.. (2022). New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer. Frontiers in Oncology. 12. 834934–834934. 20 indexed citations
3.
Wang, Shouhua, et al.. (2021). CircPVT1 promotes gallbladder cancer growth by sponging miR-339-3p and regulates MCL-1 expression. Cell Death Discovery. 7(1). 191–191. 9 indexed citations
4.
Wang, Shouhua, Tingting Su, Di Zhou, et al.. (2021). Circβ-catenin promotes tumor growth and Warburg effect of gallbladder cancer by regulating STMN1 expression. Cell Death Discovery. 7(1). 233–233. 11 indexed citations
5.
Wang, Shouhua, et al.. (2021). CircTP63 promotes cell proliferation and invasion by regulating EZH2 via sponging miR-217 in gallbladder cancer. Cancer Cell International. 21(1). 608–608. 14 indexed citations
7.
Lei, Kecheng, Xin Liang, Yuwei Gao, et al.. (2017). Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFβ2 feedback loop. Biochemical and Biophysical Research Communications. 484(3). 514–521. 72 indexed citations
8.
Lin, Shengchao, et al.. (2017). Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy. The International Journal of Biochemistry & Cell Biology. 87. 54–68. 49 indexed citations
9.
Zhang, Wenjie, Lei Chen, Honggang Xiang, et al.. (2016). Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer. BMC Biochemistry. 17(1). 19–19. 22 indexed citations
10.
Shi, Weibin, Vanminh Le, Chunhua Gu, et al.. (2014). Overcoming Multidrug Resistance in 2D and 3D Culture Models by Controlled Drug Chitosan‐Graft Poly(Caprolactone)‐Based Nanoparticles. Journal of Pharmaceutical Sciences. 103(4). 1064–1074. 18 indexed citations
11.
Shi, Weibin, et al.. (2014). Effects of amphiphilic chitosan-g-poly(ε-caprolactone) polymer additives on paclitaxel release from drug eluting implants. Materials Science and Engineering C. 45. 502–509. 11 indexed citations
12.
Le, Vanminh, Jingjing Wang, Ming Yuan, et al.. (2014). An investigation of antitumor efficiency of novel sustained and targeted 5-fluorouracil nanoparticles. European Journal of Medicinal Chemistry. 92. 882–889. 17 indexed citations
13.
Yang, Peng, Sha Jin, Jing Ding, et al.. (2013). Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. Biomaterials. 35(6). 2079–2088. 114 indexed citations
14.
Wang, Jiandong, Jun Shen, Xueping Zhou, et al.. (2013). Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer. Lasers in Medical Science. 28(6). 1541–1548. 7 indexed citations
15.
Xu, Bin, Rong Lü, Hongjing Dou, et al.. (2012). Exploring the structure–property relationships of ultrasonic/MRI dual imaging magnetite/PLA microbubbles: magnetite@Cavity versus magnetite@Shell systems. Colloid & Polymer Science. 290(16). 1617–1626. 10 indexed citations
17.
Shi, Weibin. (2012). Comparison between air and carbon dioxide insufflation in the endoscopic submucosal excavation of gastrointestinal stromal tumors. World Journal of Gastroenterology. 18(48). 7296–7296. 6 indexed citations
18.
Wang, Jiandong, Jun Shen, Xueping Zhou, et al.. (2011). Selection of range of regional lymphadenectomy for patients with T2 gallbladder cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 10(2). 100–102. 1 indexed citations
19.
Xu, Ke, et al.. (2011). miR‐1915 inhibits Bcl‐2 to modulate multidrug resistance by increasing drug‐sensitivity in human colorectal carcinoma cells. Molecular Carcinogenesis. 52(1). 70–78. 91 indexed citations
20.
Wang, Jiandong, Xuefeng Wang, Yong Yang, et al.. (2010). Value of different staging systems for gallbladder cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 9(2). 133–135. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026